COGT
Cogent Biosciences Inc
Halal Rating :
Last Price
$8.02
Last updated:
Market Cap
-
7D Change
5.94%
1 Year Change
70.64%
Company Overview
Industries
Exchange
Next Earnings Date
Cogent Biosciences Inc is a biotechnology company focused on developing precision therapies for genetically defined diseases. Their lead product candidate, bezuclastinib, is a selective and potent KIT mutant inhibitor in development for systemic mastocytosis and gastrointestinal stromal tumors (GIST). The company is currently in clinical development phase and has not yet commercialized any products.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Cogent Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.